Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Bobey

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Diagnostic Microbiology and Infectious Disease|September 1, 1992
Lack of predictability of cefotetan in vitro susceptibility tests against cefotetan-resistant anaerobic bacteria in determining clinical and bacteriologic efficaciesW Sheikh, D G Bobey
Journal of Clinical Microbiology|February 1, 1981
Rapid detection of yeast enzymes by using 4-methylumbelliferyl substratesD G Bobey, G M Ederer
World Journal of Surgery|November 1, 1994
Adjunctive antimicrobial therapy for complicated appendicitis: bacterial overkill by combination therapyJ A Hopkins, S E Wilson, D G Bobey
American Journal of Surgery|May 31, 1988
A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agentsR J Zabransky, D G Bobey, W Sheikh
The American Review of Respiratory Disease|August 1, 1985
Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assaysR J Wallace, S I Hull, D G Bobey, et al.
The American Review of Respiratory Disease|April 1, 1984
Presence of aminoglycoside acetyltransferase and plasmids in Mycobacterium fortuitum. Lack of correlation with intrinsic aminoglycoside resistanceS I Hull, R J Wallace, D G Bobey, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteriaR J Zabransky, D G Bobey, A L Barry, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Diagnostic Microbiology and Infectious Disease|September 1, 1992
Lack of predictability of cefotetan in vitro susceptibility tests against cefotetan-resistant anaerobic bacteria in determining clinical and bacteriologic efficaciesW Sheikh, D G Bobey
Journal of Clinical Microbiology|February 1, 1981
Rapid detection of yeast enzymes by using 4-methylumbelliferyl substratesD G Bobey, G M Ederer
World Journal of Surgery|November 1, 1994
Adjunctive antimicrobial therapy for complicated appendicitis: bacterial overkill by combination therapyJ A Hopkins, S E Wilson, D G Bobey
American Journal of Surgery|May 31, 1988
A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agentsR J Zabransky, D G Bobey, W Sheikh
The American Review of Respiratory Disease|August 1, 1985
Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assaysR J Wallace, S I Hull, D G Bobey, et al.
The American Review of Respiratory Disease|April 1, 1984
Presence of aminoglycoside acetyltransferase and plasmids in Mycobacterium fortuitum. Lack of correlation with intrinsic aminoglycoside resistanceS I Hull, R J Wallace, D G Bobey, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteriaR J Zabransky, D G Bobey, A L Barry, et al.
Pageof 1